KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 0.37%.

  • Eli Lilly's Return on Capital Employed rose 400.0% to 0.37% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.37%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.48% for FY2025, which is 1100.0% up from last year.
  • As of Q4 2025, Eli Lilly's Return on Capital Employed stood at 0.37%, which was up 400.0% from 0.38% recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Return on Capital Employed registered a high of 0.39% during Q2 2025, and its lowest value of 0.19% during Q1 2021.
  • For the 5-year period, Eli Lilly's Return on Capital Employed averaged around 0.28%, with its median value being 0.27% (2022).
  • In the last 5 years, Eli Lilly's Return on Capital Employed plummeted by -600bps in 2023 and then skyrocketed by 1000bps in 2024.
  • Eli Lilly's Return on Capital Employed (Quarter) stood at 0.22% in 2021, then grew by 17bps to 0.26% in 2022, then rose by 19bps to 0.3% in 2023, then grew by 9bps to 0.33% in 2024, then grew by 12bps to 0.37% in 2025.
  • Its Return on Capital Employed was 0.37% in Q4 2025, compared to 0.38% in Q3 2025 and 0.39% in Q2 2025.